Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics

Nov 15, 2025 - 08:00

Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics

Merck will pay $221.50 per share in cash for Cidara, the companies said on Friday, a premium of 108.9% from its last closing price.

Related Posts

The government shutdown is over. The air traffic controller shortage is not

The government shutdown is over. The air traffic contro...

Nov 15, 2025

Stock market's sell-off, foreclosures jump, new IRS guidelines and more in Morning Squawk

Stock market's sell-off, foreclosures jump, new IRS gui...

Nov 15, 2025

Trump has threatened the BBC with a $1 billion lawsuit. Here's what's going on

Trump has threatened the BBC with a $1 billion lawsuit....

Nov 15, 2025

Bet on Europe’s 'GOTCHA' stocks for global returns in 2026, UBS says

Bet on Europe’s 'GOTCHA' stocks for global returns in 2...

Nov 15, 2025

Billionaire families opt for buying sports teams over collecting art and cars

Billionaire families opt for buying sports teams over c...

Nov 15, 2025

Air India woes expected to keep Singapore Airlines’ earnings under pressure after 82% profit plunge, analysts warn

Air India woes expected to keep Singapore Airlines’ ear...

Nov 15, 2025